2017-03-16,Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split
2017-03-15,Tonix Pharmaceuticals To Present Breakthrough Therapy Designated-PTSD Program At Oppenheimer's 27th Annual Healthcare Conference
2017-03-14,Tonix Pharmaceuticals Receives Notice Of Allowance For New U.S. Patent Covering Composition And Manufacture Of TNX-102 SL
2017-03-07,Tonix Pharmaceuticals To Present Breakthrough Therapy Designated-PTSD Program And Corporate Update At The 29th Annual ROTH Conference
2017-03-02,Tonix Pharmaceuticals Announces Demonstrated Vaccine Activity In First-Ever Synthesized Chimeric Horsepox Virus
2017-02-28,Tonix Pharmaceuticals To Present Breakthrough Therapy Designated-PTSD Program And Corporate Update At The Cowen And Company 37th Annual Health Care Conference
2017-02-09,Tonix Pharmaceuticals To Present Breakthrough Therapy Designated-PTSD Program And Corporate Update At The 2017 BIO CEO & Investor Conference
2017-01-24,Tonix Pharmaceuticals To Present Breakthrough Therapy Designated-PTSD Program And Corporate Update At NobleCon13
2017-01-10,Tonix Pharmaceuticals Presented Details Of Newly Expanded Product Development Pipeline At 9th Annual Biotech Showcase Conference
2017-01-03,Tonix Pharmaceuticals To Present Breakthrough Therapy Designated-PTSD Program And Corporate Update At 9th Annual Biotech Showcase Conference
2016-12-19,Tonix Pharmaceuticals' PTSD Phase 3-Ready Drug Candidate, TNX-102 SL, Granted Breakthrough Therapy Designation By The FDA
2016-12-08,Tonix Pharmaceuticals Presented New Clinical Results From Sub-Group Analysis Of Phase 2 AtEase Study In Military-Related Posttraumatic Stress Disorder (PTSD)
2016-12-02,Tonix Pharmaceuticals To Present Clinical Data At The 55th Annual Meeting Of The American College Of Neuropsychopharmacology (ACNP)
2016-11-30,Tonix Pharmaceuticals To Present At 9th Annual LD Micro Main Event Investor Conference
2016-11-10,Tonix Pharmaceuticals Reports Third Quarter 2016 Financial Results
2016-11-10,Tonix Pharmaceuticals To Present New Clinical Results From Retrospective Analysis Of Phase 2 AtEase Study In Military-Related PTSD
2016-11-07,Tonix Pharmaceuticals To Present Clinical Data At The International Society For Traumatic Stress Studies (ISTSS) 32nd Annual Meeting
2016-11-02,Tonix Pharmaceuticals To Present At 22nd Annual BIO-Europe® International Partnering Conference
2016-11-01,Tonix Pharmaceuticals To Present Clinical Data At The 2016 Neuroscience Education Institute (NEI) Psychopharmacology Congress
2016-10-31,Tonix Pharmaceuticals Completes $5.2 Million Underwritten Public Offering
2016-10-27,Tonix Pharmaceuticals To Present Clinical Data At CNS Summit 2016
2016-10-26,Tonix Pharmaceuticals Prices $5.2 Million Underwritten Public Offering
2016-10-25,Tonix Pharmaceuticals Announces Proposed Underwritten Public Offering Of Common Stock And Warrants
2016-10-20,5 Stocks Poised for Major Breakouts
2016-10-19,Tonix Pharmaceuticals To Host Posttraumatic Stress Disorder (PTSD) Awareness Day
2016-10-18,UPDATE -- Tonix Pharmaceuticals To Present At Dawson James Securities 2016 Small Cap Growth Stock Conference
2016-10-13,Tonix Pharmaceuticals To Present At Dawson James Securities 2016 Small Cap Growth Stock Conference
2016-09-26,Tonix Pharmaceuticals To Present At 16th Annual Sachs Biotech In Europe Forum
2016-09-07,Tonix Pharmaceuticals To Present At Rodman & Renshaw 18th Annual Global Investment Conference
2016-09-06,Tonix Pharmaceuticals Reports Topline Results From Phase 3 AFFIRM Study Of TNX-102 SL In Fibromyalgia And Provides Corporate Update
2016-08-29,Tonix Pharmaceuticals Announces Successful End-of-Phase 2 Meeting With FDA For TNX-102 SL In Post-Traumatic Stress Disorder
2016-08-15,Tonix Pharmaceuticals Presents Poster On The Development Of TNX-102 SL For Post-Traumatic Stress Disorder (PTSD) At The 2016 Military Health System Research Symposium
2016-08-08,Tonix Pharmaceuticals Reports Second Quarter 2016 Financial Results And Provides Programs Update
2016-07-26,Tonix Pharmaceuticals Initiates Second Pivotal Phase 3 Clinical Study Of TNX-102 SL In Fibromyalgia
2016-07-12,Tonix Pharmaceuticals Announces Full Exercise And Closing Of Underwriters' Over-Allotment Option
2016-07-07,Tonix Pharmaceuticals To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
2016-06-22,Can You Catch These 6 Stocks Under $10 on Their Way Up?
2016-06-21,Tonix Pharmaceuticals Completes $10 Million Public Offering Of Common Stock
2016-06-17,Tonix Pharmaceuticals To Present At The JMP Securities Life Sciences Conference
2016-06-16,Tonix Pharmaceuticals Prices Underwritten Public Offering Of Common Stock
2016-06-15,Tonix Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2016-06-09,Tonix Pharmaceuticals Presents At EULAR Results Of A Retrospective Analysis From The Phase 2b BESTFIT Clinical Study Of TNX-102 SL In Fibromyalgia
2016-06-03,Tonix Pharmaceuticals To Present At The 2016 BIO International Convention
2016-05-31,Tonix Pharmaceuticals Presents Positive Results From Phase 2 AtEase Study Of TNX-102 SL In Post-Traumatic Stress Disorder (PTSD) At The American Society Of Clinical Psychopharmacology (ASCP) 2016 Annual Meeting
2016-05-26,Tonix Pharmaceuticals To Present Positive Results From Phase 2 AtEase Study Of TNX-102 SL In Post-Traumatic Stress Disorder At The ASCP 2016 Annual Meeting
2016-05-19,Tonix Pharmaceuticals Reports Positive Topline Results From Phase 2 AtEase Study Of TNX-102 SL In Post-Traumatic Stress Disorder (PTSD)
2016-05-13,6 Stocks Under $10 Making Big Moves Higher
2016-05-09,Tonix Pharmaceuticals Reports First Quarter 2016 Financial Results And Provides Programs Update
2016-05-02,Tonix Pharmaceuticals Completes Enrollment In Phase 3 Clinical Trial Of TNX-102 SL In Fibromyalgia
2016-04-15,Trade These 5 Breakout Stocks for Big Gains
2016-03-29,Tonix Pharmaceuticals To Present At The 10th Annual BIO Europe Spring Conference
2016-03-09,Tonix Pharmaceuticals Presents Pharmacokinetic Data On TNX-102 SL As A Potential Treatment For The Management Of Fibromyalgia And Treatment Of Post-Traumatic Stress Disorder At The ASCPT 2016 Annual Meeting
2016-03-08,Tonix Pharmaceuticals To Present At The 28th Annual ROTH Conference
2016-03-04,Tonix Pharmaceuticals Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Programs Update
2016-03-03,Tonix Pharmaceuticals To Present At Two Investor Conferences In March 2016
2016-02-25,Tonix Pharmaceuticals Appoints Chief Financial Officer
2016-02-16,Tonix Pharmaceuticals Reports Top Line Results From Phase 2 Proof-of-Concept Clinical Study Of TNX-201 In Episodic Tension-Type Headache
2016-02-02,Tonix Pharmaceuticals To Present At The 18th Annual BIO CEO & Investor Conference
2016-01-08,Tonix Pharmaceuticals Announces Management Change
2016-01-05,Tonix Pharmaceuticals To Present At Biotech Showcase 2016
2015-12-23,Tonix Pharmaceuticals Completes Enrollment In Phase 2 Clinical Trial Of TNX-102 SL In Post-Traumatic Stress Disorder (PTSD)
2015-12-08,Tonix Pharmaceuticals Completes Enrollment In Phase 2 Clinical Study Of TNX-201 In Episodic Tension-Type Headache
2015-12-07,Tonix Pharmaceuticals And U.S. Department Of Defense Military Developer In Partnership To Expand Efforts To Examine TNX-102 SL For Post-Traumatic Stress Disorder
2015-12-01,Tonix Pharmaceuticals To Participate In Fireside Chat At The Oppenheimer 26th Annual Healthcare Conference
2015-11-10,Tonix Pharmaceuticals Presents Additional Data On Tonmya(TM) Demonstrating Improvements In Sleep, Pain, And Other Outcomes In Fibromyalgia At 2015 ACR/ARHP Annual Meeting
2015-11-09,Tonix Pharmaceuticals Reports Third Quarter 2015 Financial Results And Provides Programs Update
2015-10-01,Tonix Pharmaceuticals Announces Acceptance Of Three Abstracts To Be Presented At The 2015 ACR/ARHP Annual Meeting
2015-09-24,Tonix Pharmaceuticals To Present At The 15th Annual Biotech In Europe Forum For Global Partnering And Investment
2015-09-08,Tonix Pharmaceuticals To Present At The Rodman & Renshaw Global Investment Conference
2015-08-18,Tonix Pharmaceuticals Presents On The Development Of TNX-102 SL For Post-Traumatic Stress Disorder (PTSD) At The 2015 Military Health System Research Symposium
2015-08-10,Tonix Pharmaceuticals Reports Second Quarter 2015 Financial Results And Provides Program Update
2015-07-21,Tonix Pharmaceuticals Appoints Mark T. Edgar, PhD As Senior Vice President Of Product Development
2015-07-17,Tonix Pharmaceuticals Closes $20.1 Million Public Offering Of Common Stock
2015-07-14,Tonix Pharmaceuticals (TNXP) Stock Falls After Pricing Public Offering
2015-07-14,Tonix Pharmaceuticals Prices Underwritten Public Offering Of Common Stock
2015-07-13,Tonix Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-06-22,Tonix Pharmaceuticals Presents Non-clinical Data On TNX-201 At The 57th Annual Scientific Meeting Of The American Headache Society
2015-06-17,Tonix Pharmaceuticals Announces Conditional Acceptance Of Tonmya As Proposed Brand Name For Cyclobenzaprine HCl Sublingual Tablets, 2.8 Mg
2015-06-16,Tonix Pharmaceuticals Initiates Phase 2 Clinical Study Of TNX-201 In Episodic Tension-Type Headache
2015-06-11,Tonix Pharmaceuticals Presents Additional Data From Phase 2b BESTFIT Clinical Study At EULAR
2015-05-28,Tonix Pharmaceuticals To Present At The Jefferies 2015 Global Healthcare Conference
2015-05-26,Tonix Pharmaceuticals Announces Acceptance Of Two Abstracts For Presentation At EULAR
2015-05-20,Tonix Pharmaceuticals To Present Additional Data From Completed Phase 2b Study Of TNX-102 SL In Fibromyalgia At EULAR
2015-05-15,Tonix Pharmaceuticals Presents Data At The Annual Meeting Of The Society For Biological Psychiatry
2015-05-13,Tonix Pharmaceuticals Launches Phase 3 Clinical Study Of TNX-102 SL In Fibromyalgia
2015-05-11,Tonix Pharmaceuticals Reports First Quarter 2015 Financial Results And Clinical Update
2015-03-20,Tonix Pharmaceuticals To Present At The 12th Annual BIO Asia International Conference
2015-03-04,Tonix Pharmaceuticals To Present At The 27th Annual ROTH Conference
2015-03-03,Tonix Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Financial Results
2015-03-02,Tonix Pharmaceuticals To Present At The 8th Annual European Life Sciences CEO Forum
2015-02-09,Tonix Pharmaceuticals Announces Closing Of $28.7 Million Public Offering Of Common Stock
2015-02-05,Tonix Pharmaceuticals To Present At The BIO CEO & Investor Conference
2015-02-04,Tonix Pharmaceuticals Prices Underwritten Public Offering Of Common Stock
2015-02-03,Tonix Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2015-01-15,Tonix Pharmaceuticals Commences Phase 2 Trial Of TNX-102 SL In Post-Traumatic Stress Disorder
2015-01-14,Tonix Pharmaceuticals To Present At The Noble Financial Annual Investor Conference
2015-01-09,Tonix Pharmaceuticals Announces Clinical Progress On Potential Treatment For Headache
2015-01-06,Tonix Pharmaceuticals Provides Clinical And Regulatory Update On Its Continued Development Of TNX-102 SL In Fibromyalgia
2014-11-25,Tonix Pharmaceuticals To Present At The LD Micro Investor Conference
2014-11-10,Tonix Pharmaceuticals Reports Third Quarter 2014 Financial Results
2014-10-21,Tonix Pharmaceuticals Receives IND Clearance For TNX-201 In Episodic Tension-Type Headache
2014-09-29,Why Tonix Pharmaceuticals (TNXP) Stock Is Plummeting Today
2014-09-29,Oversold Conditions For Tonix Pharmaceuticals Holding (TNXP)
2014-09-29,Tonix Pharmaceuticals Reports Top Line Results From Phase 2b BESTFIT Trial Of TNX-102 SL In Patients With Fibromyalgia
2014-09-19,Tonix Pharmaceuticals To Present At The BioCentury NewsMakers Conference
2014-09-03,Tonix Pharmaceuticals To Present At The Rodman & Renshaw Global Investment Conference
2014-08-26,3 Big-Volume Biotech Stocks to Trade for Breakouts
2014-08-11,Tonix Pharmaceuticals Announces Transfer To The NASDAQ Global Market
2014-08-08,Tonix Pharmaceuticals Reports Second Quarter 2014 Financial Results
2014-08-06,Tonix Pharmaceuticals To Present At Two Investor Conferences In August
2014-07-11,Tonix Pharmaceuticals Announces Registered Direct Offering Of $7.8 Million
2014-06-30,Tonix Pharmaceuticals Joins Russell Microcap Index
2014-06-26,Tonix Pharmaceuticals Appoints Ronald R. Notvest, Ph.D. As Senior Vice President Of Commercial Planning And Development
2014-06-24,3 Big-Volume Stocks to Trade for Breakouts
2014-06-10,Tonix Pharmaceuticals Receives IND Clearance From U.S. Food And Drug Administration For TNX-102 SL In Post-Traumatic Stress Disorder
2014-06-04,4 Under-$10 Stocks to Trade for Breakouts
2014-06-03,Tonix Appoints Gregory M. Sullivan, M.D. As Chief Medical Officer
2014-05-29,Tonix Pharmaceuticals To Present At The Jefferies 2014 Global Healthcare Conference
2014-05-29,Tonix Pharmaceuticals To Present At The LD Micro Invitational Conference
2014-05-28,Tonix Pharmaceuticals To Be Added To The MSCI Global Micro Cap Index
2014-05-28,3 Stocks Under $10 Making Big Moves
2014-05-20,Tonix Pharmaceuticals To Present At The MIXiii Biomed Conference In Israel
2014-05-13,Tonix Pharmaceuticals Reports First Quarter 2014 Financial Results
2014-05-12,Tonix Pharmaceuticals Completes Enrollment In BESTFIT Trial Of TNX-102 SL For Fibromyalgia
2014-04-09,Tonix Pharmaceuticals Spotlighted In April 7 Issue Of BioCentury
2014-04-01,Tonix Pharmaceuticals Appoints Donald J. Kellerman Senior Vice President, Clinical Development And Regulatory Affairs
2014-03-31,Tonix Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results
2014-03-05,Tonix Pharmaceuticals To Present At The ROTH Conference
2014-03-03,Tonix Pharmaceuticals Completes Pre-IND Meeting With FDA On TNX-201 For Episodic Tension-Type Headache: Clinical Development To Begin In 4Q 2014
2014-02-21,Tonix Pharmaceuticals Spotlighted In Three Media Outlets In February
2014-02-14,Tonix CEO: Investors Seeing Value in Reformulation Strategy
2014-02-04,Tonix Pharmaceuticals To Present At The BIO CEO Conference
2014-01-29,Tonix Pharmaceuticals Announces Closing Of $43.5 Million Public Offering Of Common Stock
2014-01-24,Tonix Pharmaceuticals Prices Underwritten Public Offering Raising $43.5 Million
2014-01-23,Tonix Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2013-12-27,5 Stocks Rising on Unusual Volume
2013-12-10,Tonix Pharmaceuticals Announces The Enrollment Of Completers From The BESTFIT Trial Into A 12-Month Open-Label Extension Study
2013-11-26,Tonix Pharmaceuticals To Present At The Oppenheimer Healthcare Conference
2013-11-21,Tonix Pharmaceuticals To Present At The LD Micro Conference
2013-11-13,Tonix Pharmaceuticals Reports Third Quarter 2013 Financial Results
2013-01-18,(Graphic: Business Wire)
2012-08-16,Tonix Pharmaceuticals CEO Dr. Seth Lederman Describes Potential Treatment For Fibromyalgia, Post-Traumatic Stress Disorder And Traumatic Brain Injury
2012-08-14,Tonix Pharmaceuticals Reports That Sublingual Formulation Of Fibromyalgia Drug Reduces Production Of A Psychoactive Metabolite, Improving Suitability For Long-Term, Chronic Treatment
2012-07-30,Tonix Pharmaceuticals Announces Completion Of Clinical Trial Of Sublingual TNX-102
2012-07-09,Tonix Pharmaceuticals Reports Positive Preclinical Data On Sublingual TNX-102
2012-06-27,Tonix Pharmaceuticals To Present At LHA Life Sciences &amp; Medical Technologies Virtual Conference On June 28
2012-06-27,Tonix Pharmaceuticals Receives Health Canada Clearance To Study A Novel Treatment For Fibromyalgia
2012-06-19,Tonix Pharmaceuticals To Present At Marcum MicroCap Conference
2012-06-14,Tonix Pharmaceuticals Featured On GLX-TV OpenCEOLive Series
2012-05-23,Tonix Pharmaceuticals CEO Interviewed On CEOLive.TV
2012-05-10,Tonix Pharmaceuticals Appoints Dr. Samuel Saks To Its Board Of Directors
2012-04-30,TONIX Pharmaceuticals To Present At Three Investor Conferences In May
